Douglas Lane & Associates’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$41.3M Buy
94,949
+15,077
+19% +$6.15M 0.55% 70
2026
Q2
$35.6M Buy
79,872
+17,362
+28% +$8.16M 0.48% 79
2026
Q1
$24.8M Buy
62,510
+13,780
+28% +$6.23M 0.36% 92
2025
Q4
$22.9M Buy
48,730
+47,890
+5,701% +$21.3M 0.31% 97
2025
Q3
$414K Buy
+840
New +$475K 0.01% 187

Other funds holding SNPS

Douglas Lane & Associates's SNPS Position: Q3 2026 in Review

Douglas Lane & Associates increased its Synopsys (SNPS) stake by 19% in Q3 2026, buying an estimated $6.15M and bringing the position to 94,949 shares worth $41.3M. The position accounts for 0.55% of the portfolio, ranked #70.

Douglas Lane & Associates first reported a position in SNPS in Q3 2025 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold SNPS as of Q3 2026.

  • Douglas Lane & Associates held 94,949 shares of Synopsys worth $41.3M as of Q3 2026.
  • Douglas Lane & Associates bought 15,077 Synopsys shares in Q3 2026, an estimated $6.15M.
  • Synopsys made up 0.55% of Douglas Lane & Associates's portfolio in Q3 2026, its #70 holding.
  • Douglas Lane & Associates first reported a position in Synopsys in Q3 2025 and has held it in 5 quarters since.
  • 54 funds tracked by Wall St. Rank held Synopsys as of Q3 2026.

Based on Douglas Lane & Associates's 13F filing for Q3 2026, filed 9 Oct 2026.